破裂脑动脉瘤支架辅助栓塞中抗血小板和抗凝药物的效果分析

来源 :临床合理用药杂志 | 被引量 : 0次 | 上传用户:df_871
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的分析破裂脑动脉瘤支架辅助栓塞中抗血小板和抗凝药物的应用效果。方法选取我院2015年1月-2016年1月收治的32例破裂脑动脉瘤患者为研究对象,在征得所有患者家属知情同意下在支架辅助栓塞中采用抗血小板和抗凝药物予以治疗,比较实施前后的血液流变学水平变化。结果抗血小板和抗凝药物应用后患者血液流变学指标水平优于应用前,差异具有统计学意义(P<0.05)。结论支架辅助栓塞中应用抗血小板药物和抗凝药物可显著改善患者血液循环状态,提高临床治疗效果,值得推广使用。 Objective To analyze the effect of anti-platelet and anticoagulant drugs in the treatment of ruptured cerebral aneurysm stent-assisted embolization. Methods Thirty-two patients with ruptured cerebral aneurysm admitted from January 2015 to January 2016 in our hospital were enrolled in this study. Anti-platelet and anticoagulant drugs were used to treat stent-assisted embolism with the informed consent of all patients. Comparison of changes in blood rheology before and after the implementation of changes. Results The anti-platelet and anticoagulant drugs patients blood rheology indicators better than before application, the difference was statistically significant (P <0.05). Conclusion The application of antiplatelet drugs and anticoagulant drugs in stent-assisted embolization can significantly improve the blood circulation status and improve the clinical curative effect, which is worth to promote.
其他文献
目的根据2013年全国登革热监测数据,分析我国登革热流行病学特征与趋势,探讨相应防治对策及建议。方法利用2013年“传染病报告信息管理系统”和5省监测点上报数据,进行回顾性